Roche says Actemra drug wins breakthrough therapy nod from FDA

ZURICH (Reuters) - Roche said it received breakthrough therapy designation from the U.S. health regulator for its Actemra treatment in systemic sclerosis.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Actemra | Health | Scleroderma